A new market study confirms that the global Antisense Oligonucleotide (ASO) Therapies Targeting Genetic And Rare Disorders Market is on a trajectory of phenomenal growth, driven by breakthrough science and a massive unmet medical need. The market size, valued at USD $529.26 billion in 2024, is projected to reach USD $1,563.55 billion by 2032, exhibiting a robust Compound Annual Growth... https://www.databridgemarketresearch.com/